<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02509728</url>
  </required_header>
  <id_info>
    <org_study_id>Choline and DHA for Preemies 2</org_study_id>
    <nct_id>NCT02509728</nct_id>
  </id_info>
  <brief_title>Metabolic Effects of Choline and Docosahexaenoic Acid Supplementation in Preterm Infants</brief_title>
  <official_title>Nahrungsergänzung Mit Cholin- Und Docosahexaensäure Bei Sehr Unreifen Frühgeborenen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the effects of enteral choline and DHA supplementation on plasma choline and
      DHA-PC concentrations and metabolism, this randomized controlled study will assign 40 preterm
      infants to 1 of 4 groups: standard care, choline supplementation, DHA supplementation, and
      choline and DHA supplementation.

      After 7 days of supplementation, a single dose of stable isotope labelled choline will be
      administered and the kinetics of newly synthesized DHA-PC determined to assess plasma levels,
      uptake and distribution of choline and DHA.

      This study is designed to inform larger studies evaluating this approach of enteral
      co-application of choline and DHA on clinical important outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In utero, there is a constant high supply of choline to the fetus. Preterm delivery disrupts
      this maternal-fetal choline-transfer. We have shown that choline plasma levels rapidly half
      after preterm delivery. We also demonstrated that plasma DHA-PC rapidly falls after preterm
      delivery. DHA supplementation has been evaluated and found safe, however the clinical
      benefits have been smaller than expected. We speculate that choline deficiency may have
      contributed to the smaller than expected benefit of DHA supplementation in the past.

      This study verifies the hypothesis that concomitant supply of choline and DHA will improve
      DHA-PC availability and turn-over. This is important because DHA-PC is the transport molecule
      for the DHA transport to the brain and the retina.

      To explore the effects of enteral choline and DHA supplementation on plasma choline and
      DHA-PC concentrations, this randomized controlled study will assign 40 preterm infants to 1
      of 4 groups: standard care, choline supplementation, DHA supplementation, and choline and DHA
      supplementation.

      After 7 days of supplementation, a single dose of stable isotope labelled choline will be
      administered and the kinetics of newly synthesized DHA-PC determined to assess plasma levels,
      uptake and distribution of choline and DHA.

      This study is designed to inform future larger studies evaluating this approach of enteral
      co-application of choline and DHA on important clinical outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">October 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma concentrations of choline</measure>
    <time_frame>following 7 days of supplementation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>de-novo DHA-phosphatidylcholine synthesis</measure>
    <time_frame>following 7 days of supplementation at 12hours after D9-choline administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DHA-phosphatidylcholine turnover</measure>
    <time_frame>following 7.5 days of supplementation, from 12hours to 60 hours after D9-choline administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fractions and concentrations of molecular species of phosphatidylcholine</measure>
    <time_frame>baseline and following 7.5 and 10 days of supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma concentrations of choline</measure>
    <time_frame>baseline and following 7.5 and 10 days of supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma concentrations of betaine (a metabolite of choline)</measure>
    <time_frame>baseline and following 7.5 and 10 days of supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma concentrations of dimethylglycine (a metabolite of choline)</measure>
    <time_frame>baseline and following 7.5 and 10 days of supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma concentrations of trimethylamineoxide (TMAO, a metabolite of choline)</measure>
    <time_frame>baseline and following 7.5 and 10 days of supplementation</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Infant, Premature</condition>
  <arm_group>
    <arm_group_label>standard nutrition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard nutrition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>choline supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in addition to standard nutrition: enteral supplementation with 30mg/kg choline chloride for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DHA supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in addition to standard nutrition: enteral supplementation with 60mg/kg DHA for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>choline and DHA supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in addition to standard nutrition: enteral supplementation with 30mg/kg choline chloride and 60mg/kg of DHA for 10 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>choline supplementation</intervention_name>
    <description>in addition to standard nutrition: enteral supplementation with 30mg/kg choline chloride for 10 days</description>
    <arm_group_label>choline supplementation</arm_group_label>
    <arm_group_label>choline and DHA supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA supplementation</intervention_name>
    <description>in addition to standard nutrition: enteral supplementation with 60mg/kg DHA for 10 days</description>
    <arm_group_label>DHA supplementation</arm_group_label>
    <arm_group_label>choline and DHA supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>standard nutrition</intervention_name>
    <description>standard nutrition</description>
    <arm_group_label>standard nutrition</arm_group_label>
    <arm_group_label>choline supplementation</arm_group_label>
    <arm_group_label>DHA supplementation</arm_group_label>
    <arm_group_label>choline and DHA supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preterm infants with a gestational age at birth between 24 and 32 weeks

          -  on almost complete enteral feeding (&gt;75% of total fluid intake)

        Exclusion Criteria:

          -  insufficient enteral intake,

          -  gastrointestinal disease,

          -  missing parental consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Franz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Tuebingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Bernhard W, Raith M, Kunze R, Koch V, Heni M, Maas C, Abele H, Poets CF, Franz AR. Choline concentrations are lower in postnatal plasma of preterm infants than in cord plasma. Eur J Nutr. 2015 Aug;54(5):733-41. doi: 10.1007/s00394-014-0751-7. Epub 2014 Aug 23.</citation>
    <PMID>25148882</PMID>
  </reference>
  <reference>
    <citation>Bernhard W, Raith M, Koch V, Kunze R, Maas C, Abele H, Poets CF, Franz AR. Plasma phospholipids indicate impaired fatty acid homeostasis in preterm infants. Eur J Nutr. 2014 Oct;53(7):1533-47. doi: 10.1007/s00394-014-0658-3. Epub 2014 Jan 24.</citation>
    <PMID>24464176</PMID>
  </reference>
  <reference>
    <citation>Bernhard W, Full A, Arand J, Maas C, Poets CF, Franz AR. Choline supply of preterm infants: assessment of dietary intake and pathophysiological considerations. Eur J Nutr. 2013 Apr;52(3):1269-78. doi: 10.1007/s00394-012-0438-x. Epub 2012 Sep 9.</citation>
    <PMID>22961562</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2015</study_first_submitted>
  <study_first_submitted_qc>July 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2015</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>choline</keyword>
  <keyword>docosahexaenoic acid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Choline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

